FDC Buyback 2019
(i) A young visionary, Anand Chandavarkar, in the backdrop of India’s independence struggle, dreamed of building a world-class company in 1936. His vision of freedom was to create, to build, and to industrialize, in order to make the nation self-reliant in healthcare. In 1940, this partnership firm was incorporated as a private limited company – Fairdeal Corporation (Private) Limited and in 1986 its name was changed to FDC Private Limited. Thereafter, FDC became a public limited company and was listed on the Bombay and National Stock Exchanges of India in 1996.
(ii) Today, FDC carries forward the flaming spirit of its first dream, achieving accreditations from the US-FDA, UK-MHRA, MCC-RSA, and the UAE, to cite a few.
FDC is a forerunner in manufacturing and marketing of Oral Rehydration Salts (ORS) and Ophthalmics.
FDC has also set-up globally approved, multi-location manufacturing facilities for Active Pharmaceuticals Ingredients (APIs) as well as Finished Dosage Forms. These facilities are located at Roha, Waluj and Sinnar in Maharashtra, Verna in Goa and Baddi in Himachal Pradesh.
FDC markets more than 300 products in India and exports many of these to over 50 countries.
Products of the Company in Glance
Buy Back Offer Deal:
|Buyback Type:||Tender Offer|
|Buyback Record Date:||Jun 07 2019|
|Buyback Offer Amount:||₹ 120.05 Cr|
|Date of Board Meeting approving the proposal:||May 24 2019|
|Date of Public Announcement:||May 24 2019|
|Buyback Offer Size:||<10%|
|Buyback Number of Shares:||34,30,000|
|Price Type:||Tender Offer|
|Buyback Price:||₹ 350 Per Equity Share|
Details of Buyback:
Salient financial parameters:
|Particulars( in Cr)||2018||2017||2016||2015|
How to Participate in buyback?
Profit from the buyback on the bases of acceptance Ratio:
|Amount Invested in Buyback||1,13,142||1,13,142||1,13,142||1,13,142|
|No. of Shares buyback||188||285||428||571|